• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗癌芳基磺酰胺与p300转录辅因子相互作用的结合模型

Binding Model for the Interaction of Anticancer Arylsulfonamides with the p300 Transcription Cofactor.

作者信息

Shi Qi, Yin Shaoman, Kaluz Stefan, Ni Nanting, Devi Narra Sarojini, Mun Jiyoung, Wang Danzhu, Damera Krishna, Chen Weixuan, Burroughs Sarah, Mooring Suazette Reid, Goodman Mark M, Van Meir Erwin G, Wang Binghe, Snyder James P

机构信息

Department of Chemistry, Emory University , Atlanta, Georgia 30322, United States.

Laboratory of Molecular Neuro-Oncology, Department of Neurosurgery, Emory University School of Medicine , Atlanta, Georgia 30322, United States.

出版信息

ACS Med Chem Lett. 2012 Jun 21;3(8):620-5. doi: 10.1021/ml300042k. eCollection 2012 Aug 9.

DOI:10.1021/ml300042k
PMID:24936238
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4056939/
Abstract

Hypoxia inducible factors (HIFs) are transcription factors that activate expression of multiple gene products and promote tumor adaptation to a hypoxic environment. To become transcriptionally active, HIFs associate with cofactors p300 or CBP. Previously, we found that arylsulfonamides can antagonize HIF transcription in a bioassay, block the p300/HIF-1α interaction, and exert potent anticancer activity in several animal models. In the present work, KCN1-bead affinity pull down, (14)C-labeled KCN1 binding, and KCN1-surface plasmon resonance measurements provide initial support for a mechanism in which KCN1 can bind to the CH1 domain of p300 and likely prevent the p300/HIF-1α assembly. Using a previously reported NMR structure of the p300/HIF-1α complex, we have identified potential binding sites in the p300-CH1 domain. A two-site binding model coupled with IC50 values has allowed establishment of a modest ROC-based enrichment and creation of a guide for future analogue synthesis.

摘要

缺氧诱导因子(HIFs)是激活多种基因产物表达并促进肿瘤适应缺氧环境的转录因子。为了具有转录活性,HIFs与辅因子p300或CBP结合。此前,我们发现芳基磺胺类药物在生物测定中可拮抗HIF转录,阻断p300/HIF-1α相互作用,并在多种动物模型中发挥强大的抗癌活性。在本研究中,KCN1磁珠亲和下拉、(14)C标记的KCN1结合以及KCN1表面等离子体共振测量为KCN1可结合p300的CH1结构域并可能阻止p300/HIF-1α组装的机制提供了初步支持。利用先前报道的p300/HIF-1α复合物的NMR结构,我们在p300-CH1结构域中确定了潜在的结合位点。结合IC50值的双位点结合模型实现了基于适度ROC的富集,并为未来类似物的合成创建了指导。

相似文献

1
Binding Model for the Interaction of Anticancer Arylsulfonamides with the p300 Transcription Cofactor.抗癌芳基磺酰胺与p300转录辅因子相互作用的结合模型
ACS Med Chem Lett. 2012 Jun 21;3(8):620-5. doi: 10.1021/ml300042k. eCollection 2012 Aug 9.
2
Arylsulfonamide KCN1 inhibits in vivo glioma growth and interferes with HIF signaling by disrupting HIF-1α interaction with cofactors p300/CBP.芳基磺酰胺 KCN1 通过破坏 HIF-1α 与共因子 p300/CBP 的相互作用来抑制体内神经胶质瘤的生长并干扰 HIF 信号。
Clin Cancer Res. 2012 Dec 15;18(24):6623-33. doi: 10.1158/1078-0432.CCR-12-0861. Epub 2012 Aug 24.
3
Functional role of p35srj, a novel p300/CBP binding protein, during transactivation by HIF-1.新型p300/CBP结合蛋白p35srj在缺氧诱导因子-1反式激活过程中的功能作用
Genes Dev. 1999 Jan 1;13(1):64-75. doi: 10.1101/gad.13.1.64.
4
Structural basis for negative regulation of hypoxia-inducible factor-1alpha by CITED2.CITED2对缺氧诱导因子-1α负调控的结构基础
Nat Struct Biol. 2003 Jul;10(7):504-12. doi: 10.1038/nsb936.
5
Recent Advances in the Discovery of HIF-1α-p300/CBP Inhibitors as Anti-Cancer Agents.作为抗癌药物的HIF-1α-p300/CBP抑制剂发现的最新进展
Mini Rev Med Chem. 2018;18(4):296-309. doi: 10.2174/1389557516666160630124938.
6
Menadione and ethacrynic acid inhibit the hypoxia-inducible factor (HIF) pathway by disrupting HIF-1α interaction with p300.亚甲二氢叶酸和乙磺酸抑制缺氧诱导因子(HIF)通路,通过破坏 HIF-1α 与 p300 的相互作用。
Biochem Biophys Res Commun. 2013 May 17;434(4):879-84. doi: 10.1016/j.bbrc.2013.04.044. Epub 2013 Apr 22.
7
CTK7A, a curcumin derivative, can be a potential candidate for targeting HIF-1α/p300 complex: Evidences from in vitro and computational studies.CTK7A,一种姜黄素衍生物,可以成为靶向 HIF-1α/p300 复合物的潜在候选物:来自体外和计算研究的证据。
Biophys Chem. 2022 Aug;287:106828. doi: 10.1016/j.bpc.2022.106828. Epub 2022 May 18.
8
Insights from molecular dynamics simulations and steered molecular dynamics simulations to exploit new trends of the interaction between HIF-1α and p300.从分子动力学模拟和导向分子动力学模拟中获得的见解,以利用 HIF-1α 和 p300 之间相互作用的新趋势。
J Biomol Struct Dyn. 2020 Jan;38(1):1-12. doi: 10.1080/07391102.2019.1580616. Epub 2019 Mar 4.
9
Complex regulation of the transactivation function of hypoxia-inducible factor-1 alpha by direct interaction with two distinct domains of the CREB-binding protein/p300.缺氧诱导因子-1α的反式激活功能受与其结合蛋白/ p300 两个不同结构域的直接相互作用的复杂调控。
J Biol Chem. 2010 Jan 22;285(4):2601-9. doi: 10.1074/jbc.M109.021824. Epub 2009 Oct 30.
10
Structural Elucidation and Synthesis of Eudistidine A: An Unusual Polycyclic Marine Alkaloid that Blocks Interaction of the Protein Binding Domains of p300 and HIF-1α.优地他丁A的结构解析与合成:一种可阻断p300和HIF-1α蛋白结合结构域相互作用的特殊多环海洋生物碱
J Am Chem Soc. 2015 Apr 29;137(16):5569-75. doi: 10.1021/jacs.5b02156. Epub 2015 Apr 20.

引用本文的文献

1
Arylsulfonamide 64B Inhibits Hypoxia/HIF-Induced Expression of c-Met and CXCR4 and Reduces Primary Tumor Growth and Metastasis of Uveal Melanoma.芳基磺酰胺 64B 抑制缺氧/HIF 诱导的 c-Met 和 CXCR4 的表达,减少葡萄膜黑色素瘤的原发肿瘤生长和转移。
Clin Cancer Res. 2019 Apr 1;25(7):2206-2218. doi: 10.1158/1078-0432.CCR-18-1368. Epub 2018 Dec 18.
2
Modulating the masters: chemical tools to dissect CBP and p300 function.调控主控子:解析 CBP 和 p300 功能的化学工具。
Curr Opin Chem Biol. 2018 Aug;45:195-203. doi: 10.1016/j.cbpa.2018.06.005. Epub 2018 Jul 17.
3
Purifying Properly Folded Cysteine-rich, Zinc Finger Containing Recombinant Proteins for Structural Drug Targeting Studies: the CH1 Domain of p300 as a Case Example.为进行结构药物靶向研究纯化正确折叠的富含半胱氨酸的含锌指重组蛋白:以p300的CH1结构域为例
Bio Protoc. 2017 Sep 5;7(17). doi: 10.21769/BioProtoc.2537.
4
Examining the structure-activity relationship of benzopyran-based inhibitors of the hypoxia inducible factor-1 pathway.研究基于苯并吡喃的缺氧诱导因子-1通路抑制剂的构效关系。
Bioorg Med Chem Lett. 2017 Apr 15;27(8):1731-1736. doi: 10.1016/j.bmcl.2017.02.073. Epub 2017 Mar 1.
5
Targeting Protein-Protein Interactions in the HIF System.靶向缺氧诱导因子(HIF)系统中的蛋白质-蛋白质相互作用
ChemMedChem. 2016 Apr 19;11(8):773-86. doi: 10.1002/cmdc.201600012. Epub 2016 Mar 21.
6
Biology of advanced uveal melanoma and next steps for clinical therapeutics.晚期葡萄膜黑色素瘤生物学及临床治疗的下一步措施
Pigment Cell Melanoma Res. 2015 Mar;28(2):135-47. doi: 10.1111/pcmr.12304. Epub 2014 Sep 1.
7
Hypoxia inducible factor pathway inhibitors as anticancer therapeutics.缺氧诱导因子通路抑制剂作为抗癌治疗药物。
Future Med Chem. 2013 Apr;5(5):553-72. doi: 10.4155/fmc.13.17.
8
KCN1, a novel synthetic sulfonamide anticancer agent: in vitro and in vivo anti-pancreatic cancer activities and preclinical pharmacology.KCN1,一种新型的合成磺胺类抗癌剂:体外和体内抗胰腺癌活性及临床前药理学研究。
PLoS One. 2012;7(9):e44883. doi: 10.1371/journal.pone.0044883. Epub 2012 Sep 13.
9
Arylsulfonamide KCN1 inhibits in vivo glioma growth and interferes with HIF signaling by disrupting HIF-1α interaction with cofactors p300/CBP.芳基磺酰胺 KCN1 通过破坏 HIF-1α 与共因子 p300/CBP 的相互作用来抑制体内神经胶质瘤的生长并干扰 HIF 信号。
Clin Cancer Res. 2012 Dec 15;18(24):6623-33. doi: 10.1158/1078-0432.CCR-12-0861. Epub 2012 Aug 24.
10
Design and in vitro activities of N-alkyl-N-[(8-R-2,2-dimethyl-2H-chromen-6-yl)methyl]heteroarylsulfonamides, novel, small-molecule hypoxia inducible factor-1 pathway inhibitors and anticancer agents.新型小分子低氧诱导因子-1 通路抑制剂和抗癌剂 N-烷基-N-[(8-R-2,2-二甲基-2H-色烯-6-基)甲基]杂芳基磺酰胺的设计与体外活性
J Med Chem. 2012 Aug 9;55(15):6738-50. doi: 10.1021/jm300752n. Epub 2012 Jul 24.

本文引用的文献

1
KCN1, a novel synthetic sulfonamide anticancer agent: in vitro and in vivo anti-pancreatic cancer activities and preclinical pharmacology.KCN1,一种新型的合成磺胺类抗癌剂:体外和体内抗胰腺癌活性及临床前药理学研究。
PLoS One. 2012;7(9):e44883. doi: 10.1371/journal.pone.0044883. Epub 2012 Sep 13.
2
Arylsulfonamide KCN1 inhibits in vivo glioma growth and interferes with HIF signaling by disrupting HIF-1α interaction with cofactors p300/CBP.芳基磺酰胺 KCN1 通过破坏 HIF-1α 与共因子 p300/CBP 的相互作用来抑制体内神经胶质瘤的生长并干扰 HIF 信号。
Clin Cancer Res. 2012 Dec 15;18(24):6623-33. doi: 10.1158/1078-0432.CCR-12-0861. Epub 2012 Aug 24.
3
Design and in vitro activities of N-alkyl-N-[(8-R-2,2-dimethyl-2H-chromen-6-yl)methyl]heteroarylsulfonamides, novel, small-molecule hypoxia inducible factor-1 pathway inhibitors and anticancer agents.新型小分子低氧诱导因子-1 通路抑制剂和抗癌剂 N-烷基-N-[(8-R-2,2-二甲基-2H-色烯-6-基)甲基]杂芳基磺酰胺的设计与体外活性
J Med Chem. 2012 Aug 9;55(15):6738-50. doi: 10.1021/jm300752n. Epub 2012 Jul 24.
4
Structure-activity relationship of 2,2-dimethyl-2H-chromene based arylsulfonamide analogs of 3,4-dimethoxy-N-[(2,2-dimethyl-2H-chromen-6-yl)methyl]-N-phenylbenzenesulfonamide, a novel small molecule hypoxia inducible factor-1 (HIF-1) pathway inhibitor and anti-cancer agent.2,2-二甲基-2H-色烯基芳基磺酰胺类似物的构效关系研究,该类似物是一种新型小分子低氧诱导因子-1(HIF-1)通路抑制剂和抗癌剂,其结构基于 3,4-二甲氧基-N-[(2,2-二甲基-2H-色烯-6-基)甲基]-N-苯基苯磺酰胺。
Bioorg Med Chem. 2012 Jul 15;20(14):4590-7. doi: 10.1016/j.bmc.2012.04.064. Epub 2012 May 14.
5
Hypoxia-inducible factors in physiology and medicine.缺氧诱导因子在生理学和医学中的作用
Cell. 2012 Feb 3;148(3):399-408. doi: 10.1016/j.cell.2012.01.021.
6
Design and synthesis of novel small-molecule inhibitors of the hypoxia inducible factor pathway.新型低氧诱导因子通路小分子抑制剂的设计与合成。
J Med Chem. 2011 Dec 22;54(24):8471-89. doi: 10.1021/jm201018g. Epub 2011 Nov 23.
7
Emerging role of surface plasmon resonance in fragment-based drug discovery.表面等离子体共振在基于片段的药物发现中的新兴作用。
Future Med Chem. 2011 Oct;3(14):1809-20. doi: 10.4155/fmc.11.128.
8
Surface plasmon resonance for proteomics.用于蛋白质组学的表面等离子体共振
Methods Mol Biol. 2012;800:33-53. doi: 10.1007/978-1-61779-349-3_4.
9
Sulfonamides as a new scaffold for hypoxia inducible factor pathway inhibitors.磺胺类药物作为缺氧诱导因子通路抑制剂的新骨架。
Bioorg Med Chem Lett. 2011 Sep 15;21(18):5528-32. doi: 10.1016/j.bmcl.2011.06.099. Epub 2011 Jun 28.
10
Identification of a novel small molecule HIF-1alpha translation inhibitor.一种新型小分子HIF-1α翻译抑制剂的鉴定。
Clin Cancer Res. 2009 Oct 1;15(19):6128-36. doi: 10.1158/1078-0432.CCR-08-3180. Epub 2009 Sep 29.